Madrigal Pharmaceuticals (MDGL) PT Raised to $193 at Canaccord Genuity Ahead of EASL
Tweet Send to a Friend
Canaccord Genuity analyst Edward Nash raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $193.00 (from $179.00) on the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
